Translational investigations in the HN1901 phase II window-of-opportunity study investigating the biological activity of an IDO1 (IO102) and PD-L1 (IO103) immune-modulatory peptide cancer vaccines in squamous cell carcinoma of the head and neck. - Beyaert S; Loriot A; Magremanne M; Renwart W; Mahy P; Duprez T; Baldin P; Benidovskaya E; Huyghe N; Dahou H; Stroobant V; Gomard T; et al. (European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025)